VYNE Therapeutics to Present at Piper Sandler 34th Annual Healthcare Conference

18.11.2022 - BRIDGEWATER, N.J., Nov. 18, 2022 (GLOBE NEWSWIRE) - VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of ...

Related Keywords

David Domzalski , Tyler Zeronda , John Fraunces , Piper Sandler , Exchange Commission , Therapeutics Inc , Lifesci Advisors , Altay Therapeutics , Nasdaq , Chief Executive Officer , Annual Healthcare Conference , Annual Healthcare , Sci Advisors ,